Free Trial

Extendicare Q3 2023 Earnings Report

Extendicare logo
C$10.02 -0.10 (-0.99%)
(As of 12/18/2024 05:28 PM ET)

Extendicare EPS Results

Actual EPS
C$0.14
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Extendicare Revenue Results

Actual Revenue
$322.53 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Extendicare Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Uncover the Top Gold Stock of the Bull Market (Ad)

Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?

Click here to see how this opportunity could transform your portfolio.

Extendicare Earnings Headlines

Forbes rich list released… #1 to be assassinated?
Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.
Where to Invest $5,000 in October
See More Extendicare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Extendicare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Extendicare and other key companies, straight to your email.

About Extendicare

Extendicare (TSE:EXE), through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

View Extendicare Profile

More Earnings Resources from MarketBeat

Upcoming Earnings